SoftOx Solutions AS is pleased to invite investors, analysts and other stakeholders to our extended 2Q 2022 results presentation onMonday August 15th, 2022 . The event will be held in-person as well as being streamed live. The interim report and related materials will be made available on https://soft-ox.com/financial-calendar-reports/. The 2Q 2022 results will be released at 07:00 (CET) onMonday August 15th, 2022 and will be presented by the management at 10:00 (CET) at SpareBank 1 Markets, Olav V's gate 5,Norway . The presentation is open to the public and can also be followed via the link: https://channel.royalcast.com/landingpage/hegnarmedia/20220815_2/ The presentation will be held in English and followed by a Q&A session. Please register for the event beforeAugust 15th , at 08:00 (CET), by sending your registration to corporateaccess@sb1markets.no For any questions or interview requests, please contact: Geir Almås, CEO ofSoftOx Solutions AS , or Kristine Rød, CFO atSoftOx Solutions AS Mail: ir@soft-ox.com Phone: Front Desk: (+47) 948-59-599 AboutSoftOx Solutions AS SoftOx Solutions AS (SoftOx, listed on Euronext Growth Oslo) is a Norwegian medtech/biotech company based inOslo with the aim of helping to combat major threats to human health, namely the emergence of antimicrobial resistance (AMR), biofilm infections in chronic wounds and the spread of viruses. For more information on SoftOx, visit www.soft-ox.com
Click here for more information
© Oslo Bors ASA, source